• Filing Date: 2019-05-14
  • Form Type: 10-Q/A
  • Description: Quarterly report (Amendment)
v3.19.1
BALANCE SHEETS - USD ($)
Mar. 31, 2019
Sep. 30, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 5,514,013 $ 10,310,044
Receivables 123,236 118,657
Prepaid expenses 355,948 364,622
Inventory used for R&D and manufacturing 761,012 645,238
Total current assets 6,754,209 11,438,561
Plant, property and equipment, net 16,086,828 16,218,851
Patent costs, net 243,253 258,093
Deposits 1,670,917 1,670,917
Total Assets 24,755,207 29,586,422
CURRENT LIABILITIES:    
Accounts payable 4,158,732 5,743,913
Accrued expenses 287,890 205,310
Due to employees 1,010,015 764,941
Derivative instruments, current portion 0 2,498,606
Other current liabilities 13,984 14,029
Total current liabilities 5,470,621 9,226,799
Derivative instruments - net of current portion 4,727,929 6,818,458
Lease Liability 13,444,394 13,379,962
Deferred income 126,849 126,795
Other liabilities 29,892 33,492
Total liabilities 23,799,685 29,585,506
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding 0 0
Common stock, $.01 par value - 600,000,000 shares authorized; 29,951,628 and 28,034,487 shares issued and outstanding at March 31, 2019 and September 30, 2018, respectively 299,517 280,346
Additional paid-in capital 337,449,398 331,312,184
Accumulated deficit (336,793,393) (331,591,614)
Total stockholders' equity 955,522 916
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 24,755,207 $ 29,586,422